LATE-BREAKING CLINICAL SCIENCE | STRUCTURAL II

Monday, March 10, 2025

2:00 PM – 3:30 PM ET

Moderator(s)

Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Panelist(s)

Gregory P. Fontana, MD

Director, CardioVascular Institute
Hospital Corporation of America
Thousand oaks, United States

Disclosure(s): 4C Medical Technologies, Inc.: Grant/Research Support (Ongoing); Abbott: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Emblock: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Grant/Research Support (Ongoing)
Danny Dvir, MD

MD
SZMC, Israel

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); Pi-Cardia: Consultant (Ongoing)
Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

Professor and Clinical Director of Interventional cardiology
Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)
Santiago Garcia, MD

Director, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease
The Christ Hospital
Cincinnati, Ohio, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Bruce J. Rutkin, MD

Director of Structural Heart Disease
Northwell Health
Manhasset, New York, United States

Disclosure(s): Abbott Vascular,: Consultant (Ongoing); Edwards Lifesciences: Consultant (Ongoing); Medtronic Inc: Consultant (Ongoing)

Disclosure(s):

Samir R. Kapadia, MD, FSCAI: No financial relationships to disclose

Ron Waksman, MD, MSCAI: Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Gregory P. Fontana, MD: 4C Medical Technologies, Inc.: Grant/Research Support (Ongoing); Abbott: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Emblock: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Grant/Research Support (Ongoing)

Danny Dvir, MD: Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); Pi-Cardia: Consultant (Ongoing)

Nicolas M. Van Mieghem, MD, PhD, FESC, FACC: Abbott Medical NL BV: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing); Adjust Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Alleviant Medial Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); AncorValve: Consulting Fees (e.g., advisory boards) (Ongoing); Anteris: Consulting Fees (e.g., advisory boards) (Ongoing); Approxima Srl: Consulting Fees (e.g., advisory boards) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo: Consulting Fees (e.g., advisory boards) (Ongoing); Ladera: Consulting Fees (e.g., advisory boards) (Ongoing); LUMA Vision: Consulting Fees (e.g., advisory boards) (Ongoing); Materialise: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pie Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Polares: Consulting Fees (e.g., advisory boards) (Ongoing); PulseCath BV: Consulting Fees (e.g., advisory boards) (Ongoing); Secure Closure: Consulting Fees (e.g., advisory boards) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Grant/Research Support (Ongoing); Vivasure: Consulting Fees (e.g., advisory boards) (Ongoing)

Santiago Garcia, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Bruce J. Rutkin, MD: Abbott Vascular,: Consultant (Ongoing); Edwards Lifesciences: Consultant (Ongoing); Medtronic Inc: Consultant (Ongoing)